Lifescan Inc is categorized under Blood Derivative Diagnostic Agents in Milpitas, CA and active since 1986.
Lifescan Inc was established in 1986, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Blood Derivative Diagnostic Agents business, which does work in the B2B market, and is classified as a Blood Derivative Diagnostic Agents, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact John Lipman, Manager at the company’s single location by writing to 1000 Gibraltar Drive, Milpitas, California CA 95035 or by phoning (408) 263-9789. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lifescan Inc |
| Contact Person: | John Lipman, Manager |
| Address: | 1000 Gibraltar Drive, Milpitas, California 95035 |
| Phone Number: | (408) 263-9789 |
| Website Address: | lifescan.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1986 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Blood Derivative Diagnostic Agents |
| SIC Code: | 2835 |
| NAICS Code: | 6215110 |
| Share This Business: |
Lifescan Inc was started in 1986 to provide professional Blood Derivative Diagnostic Agents under the SIC code 2835 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact John Lipman, Manager for inquiries that concern Lifescan Inc by calling the company number (408) 263-9789, as your correspondence is most welcome. Additionally, the physical location of the single location of Lifescan Inc can be found at the coordinates 37.417848,-121.891211 as well as the street address 1000 Gibraltar Drive in Milpitas, California 95035.
For its online presence, you may visit Lifescan Inc’s website at lifescan.com and engage with its social media outlets through on Twitter and on Facebook.